Recs

0
Player Avatar Zhraath (45.61) Submitted: 5/7/2012 1:39:40 PM : Outperform Start Price: $10.61 SPPI Score: -66.56

it's highly unlikely that a cancer patient will switch to the generic alternative. This has to be the most undervalued stock I've seen in a long time.

Featured Broker Partners


Advertisement